Tumor necrosis factor-α : A mediator of disease progression in the failing human heart
HERRERA-GARZA, E. H, STETSON, S. J, CUBILLOS-GARZON, A, VOOLETICH, M. T, FARMER, J. A, TORRE-AMIONE, G
Published in Chest (01.04.1999)
Published in Chest (01.04.1999)
Get full text
Journal Article
A Pilot Safety Trial of Prolonged (48 h) Infusion of the Dual Endothelin-Receptor Antagonist Tezosentan in Patients With Advanced Heart Failure
Torre-Amione, Guillermo, Durand, Jean-Bernard, Nagueh, Sheriff, Vooletich, Mary T., Kobrin, Isaac, Pratt, Craig
Published in Chest (01.08.2001)
Published in Chest (01.08.2001)
Get full text
Journal Article
Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment
EWER, Michael S, VOOLETICH, Mary T, DURAND, Jean-Bernard, WOODS, Myrshia L, DAVIS, Joseph R, VALERO, Vicente, LENIHAN, Daniel J
Published in Journal of clinical oncology (01.11.2005)
Published in Journal of clinical oncology (01.11.2005)
Get full text
Journal Article
A mathematical model for doxorubicin cardiotoxicity: Added evidence for the concept of sequential stress
Ewer, M. S., Vooletich, M. T., Benjamin, R. S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A mathematical model for doxorubicin cardiotoxicity: Added evidence for the concept of sequential stress
Ewer, M. S., Vooletich, M. T., Benjamin, R. S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article